KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Debt Repayments (2017 - 2025)

Bristol Myers Squibb (BMY) has disclosed Long-Term Debt Repayments for 15 consecutive years, with $10.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $10.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $12.8 billion, a 344.66% increase, with the full-year FY2025 number at $10.9 billion, up 280.79% from a year prior.
  • Long-Term Debt Repayments was $10.1 billion for Q4 2025 at Bristol Myers Squibb, up from $229.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $10.1 billion in Q4 2025 to a low of $229.0 million in Q3 2025.
  • A 5-year average of $2.7 billion and a median of $2.0 billion in 2023 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: skyrocketed 457.0% in 2022, then crashed 91.69% in 2023.
  • Bristol Myers Squibb's Long-Term Debt Repayments stood at $500.0 million in 2021, then surged by 457.0% to $2.8 billion in 2022, then dropped by 28.19% to $2.0 billion in 2023, then increased by 23.9% to $2.5 billion in 2024, then soared by 306.3% to $10.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Long-Term Debt Repayments are $10.1 billion (Q4 2025), $229.0 million (Q3 2025), and $2.5 billion (Q3 2024).